litlas
Log inCreate account

Yiping Zhang

Active 1991–2026

Also published as
Yiping ZHANG
296
Papers
24,858
Citations
75
h-index
225
i10-index

Citations

Citations per year for Yiping Zhang1982: 1 citations1992: 1 citations1993: 2 citations1994: 8 citations1995: 18 citations1996: 13 citations1997: 13 citations1998: 10 citations1999: 19 citations2000: 8 citations2001: 13 citations2002: 9 citations2003: 6 citations2004: 15 citations2005: 7 citations2006: 14 citations2007: 5 citations2008: 12 citations2009: 17 citations2010: 20 citations2011: 52 citations2012: 99 citations2013: 166 citations2014: 208 citations2015: 197 citations2016: 184 citations2017: 184 citations2018: 222 citations2019: 731 citations2020: 861 citations2021: 1,091 citations2022: 1,144 citations2023: 923 citations2024: 1,579 citations2025: 801 citations2026: 35 citations1983–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,481 citing papers, 31% of this breakdownUnited States: 2,034 citing papers, 18.1% of this breakdownUnited Kingdom: 582 citing papers, 5.2% of this breakdownJapan: 404 citing papers, 3.6% of this breakdownItaly: 389 citing papers, 3.5% of this breakdownGermany: 383 citing papers, 3.4% of this breakdownFrance: 314 citing papers, 2.8% of this breakdownCanada: 285 citing papers, 2.5% of this breakdownSpain: 257 citing papers, 2.3% of this breakdownAustralia: 252 citing papers, 2.2% of this breakdownSouth Korea: 245 citing papers, 2.2% of this breakdownIndia: 212 citing papers, 1.9% of this breakdown
0%31%Other 21.3%

Institutions

Fields

  • Medicine57.4%
  • Biochemistry, Genetics and Molecular Biology16.3%
  • Nursing8.3%
  • Agricultural and Biological Sciences3.6%
  • Computer Science3.1%
  • Environmental Science2.7%
  • Other8.6%

Topics

  • Lung Cancer Treatments and Mutations7.7%
  • PARP inhibition in cancer therapy5%
  • Cancer Immunotherapy and Biomarkers4.5%
  • Lung Cancer Research Studies4%
  • DNA Repair Mechanisms3.3%
  • Food composition and properties2.9%
  • Other72.6%

Coauthors

All papers

Open in search
  1. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

    Authors: Junko Murai, Shar-yin N. Huang, Benu Brata Das, Amèlie Renaud, Yiping Zhang, James H. Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier - Cancer Research 2012 cited by 2,179

  2. Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Authors: Hui Luo, Jin Lü, Yuxian Bai, Teng Mao, Jun Wang, Qingxia Fan, Yiping Zhang, Kuaile Zhao, Zhendong Chen, Shegan Gao, Jiancheng Li, Zhichao Fu, Kangsheng Gu, Zhihua Liu, Lin Wu, Xiaodong Zhang, Ji‐Feng Feng, Zuoxing Niu, Yi Ba, Helong Zhang, Ying Liu, Li Zhang, Xuhong Min, Jing Huang, Ying Cheng, Dong Wang, Yu Shen, Qing Yang, Jianjun Zou, Rui‐Hua Xu, ESCORT-1st Investigators, Xianglin Yuan, Dong Ma, Emily Liu, Feng Ye, Tianshu Liu, Xiuwen Wang, Likun Liu, Bing Xia, Fengming Ran, Sanyuan Sun, Zhanhui Miao, Jun Bie, Yong Gao, Junyan Yu, Li Chen, Yifu He, Wei Ren, Suxia Luo, Guangqiang Zhao, Youen Lin, Long Chen, Zhiyuan Guo, Chunhong Hu, Ying Wang, Nong Xu, Baofu Chen, Xianbao Zhan, Yuping Chen, Hongda Lu, Shukui Qin, Guolei Wang, Liming Chen, Li Bai, Jingdong Zhang - JAMA 2021 cited by 801

  3. Basic principles in starch multi-scale structuration to mitigate digestibility: A review

    Authors: Chengdeng Chi, Xiaoxi Li, Shuangxia Huang, Ling Chen, Yiping Zhang, Lin Li, Song Miao - Trends in Food Science & Technology 2021 cited by 344

  4. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

    Authors: Caicun Zhou, Yi‐Long Wu, Gongyan Chen, Jifeng Feng, Xiao-Qing Liu, Changli Wang, Shucai Zhang, Jie Wang, Songwen Zhou, Shengxiang Ren, Shun Lü, Li Zhang, Chengping Hu, Chunhong Hu, Yi Luo, Lei Chen, Ming Ye, Jianan Huang, Xiuyi Zhi, Yiping Zhang, Qingyu Xiu, Jun Ma, L Zhang, Changxuan You - The Lancet Oncology 2011 cited by 4,102

  5. Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

    Authors: Jing Huang, Jianming Xu, Yun Chen, Wu Zhuang, Yiping Zhang, Zhendong Chen, Jia Chen, Helong Zhang, Zuoxing Niu, Qingxia Fan, Lizhu Lin, Kangsheng Gu, Ying Liu, Yi Ba, Zhanhui Miao, Xiaodong Jiang, Ming Zeng, Jianhua Chen, Zhichao Fu, Lu Gan, Jun Wang, Xianbao Zhan, Tianshu Liu, Zhiping Li, Lin Shen, Yongqian Shu, Tao Zhang, Qing Yang, Jianjun Zou, Suxia Luo, Feng Peng, Gang Wu, Nong Xu, Lin Zhao, Dong Ma, Shukui Qin, Wei Ren, Enxiao Li, Hongda Lu, Yueyin Pan, Jianping Xiong, Ying Yuan, Yuxian Bai, Lei Chen, Yi Hu, Li Zhang, Yong Gao - The Lancet Oncology 2020 cited by 584

  6. Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

    Authors: Shengxiang Ren, Jianhua Chen, Xingxiang Xu, Tao Jiang, Ying Cheng, Gongyan Chen, Yueyin Pan, Yong Fang, Qiming Wang, Yunchao Huang, Wenxiu Yao, Rui Wang, Xingya Li, Wei Zhang, Yanjun Zhang, Sheng Hu, Renhua Guo, Jianhua Shi, Zhiwu Wang, Peiguo Cao, Donglin Wang, Jian Fang, Hui Luo, Yi Geng, Chunyan Xing, Dongqing Lv, Yiping Zhang, Junyan Yu, Shundong Cang, Zeyu Yang, Wei Shi, Jianjun Zou, Caicun Zhou - Journal of Thoracic Oncology 2021 cited by 313

  7. Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

    Authors: Caicun Zhou, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Fengying Wu, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, Liping Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Tao Zhang, Wei Shi, Jianjun Zou - The Lancet Respiratory Medicine 2020 cited by 505

  8. Modulating the in vitro digestibility and predicted glycemic index of rice starch gels by complexation with gallic acid

    Authors: Chengdeng Chi, Xiaoxi Li, Yiping Zhang, Ling Chen, Fengwei Xie, Lin Li, Guanghui Bai - Food Hydrocolloids 2018 cited by 168

  9. DAFA-BiLSTM: Deep Autoregression Feature Augmented Bidirectional LSTM network for time series prediction

    Authors: Heshan Wang, Yiping Zhang, Jing Liang, Lili Liu - Neural Networks 2022 cited by 108

  10. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

    Authors: Yi‐Long Wu, Ying Cheng, Jianying Zhou, Shun Lü, Yiping Zhang, Jun Zhao, Dong‐Wan Kim, Ross A. Soo, Sang‐We Kim, Hongming Pan, Yuh‐Min Chen, Chih‐Feng Chian, Xiaoqing Liu, Daniel S.W. Tan, Rolf Bruns, Josef Straub, Andreas Johne, J. Scheele, Keunchil Park, James Chih‐Hsin Yang, Yi‐Long Wu, Xiaoqing Liu, Zhe Liu, Shun Lu, Xi Chen, Hongming Pan, Mengzhao Wang, YU Shi-ying, Helong Zhang, Yiping Zhang, Jian Fang, Wei Li, Jianying Zhou, Jun Zhao, Ying Cheng, Chih-Hsin Yang, Gee‐Chen Chang, Yuh‐Min Chen, Te‐Chun Hsia, Chih‐Feng Chian, Cheng-Ta Yang, Chin‐Chou Wang, Sang‐We Kim, Keunchil Park, Dong‐Wan Kim, Byoung Chul Cho, Ki Hyeong Lee, Young‐Chul Kim, Ho Jung An, In Sook Woo, Y. Choi, Sang Won Shin, Jong Seok Lee, Joo-Hang Kim, Seung Soo Yoo, Terufumi Kato, Naofumi Shinagawa, Ross A. Soo, Shao Weng Daniel Tan, Lynette Si-Mien Ngo, Kananathan Ratnavelu, Azura Rozila Ahmad, Chong Kin Liam, Filippo de Marinis, Pierfrancesco Tassone, Amelia Insa Molla, Antonio Calles, Martín Emilio Lázaro Quintela, Enriqueta Felip Font, Anne‐Marie C. Dingemans, Lynne A. Bui - The Lancet Respiratory Medicine 2020 cited by 258

  11. Pupils' Cognitive Development through Technological Experiences Mediated by the Teacher

    Authors: Ying Gao, Wei Wei, Zhongqi Fan, Xiaodan Zhao, Yiping Zhang, Jing Yuan, Benzhong Zhu, Hongliang Zhu, Wei Shan, Jianye Chen, Donald Grierson, Yunbo Luo, Tomislav Jemrić, Cai‐Zhong Jiang, Daqi Fu - Journal of Experimental Botany, Exploring a New Partnership: Children, Teachers and Technology 1994 cited by 231

  12. Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib

    Authors: Junko Murai, Shar-yin N. Huang, Amèlie Renaud, Yiping Zhang, Jiuping Ji, Shunichi Takeda, Joel Morris, Beverly A. Teicher, James H. Doroshow, Yves Pommier - Molecular Cancer Therapeutics 2013 cited by 758

  13. A NAC transcription factor, NOR-like1, is a new positive regulator of tomato fruit ripening

    Authors: Ying Gao, Wei Wei, Xiaodan Zhao, Xiaoli Tan, Zhongqi Fan, Yiping Zhang, Jing Yuan, Lanhuan Meng, Benzhong Zhu, Hongliang Zhu, Jianye Chen, Cai‐Zhong Jiang, Donald Grierson, Yunbo Luo, Daqi Fu - Horticulture Research 2018 cited by 303

  14. Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

    Authors: Yi‐Long Wu, Shun Lü, Ying Cheng, Caicun Zhou, Jie Wang, Tony Mok, Li Zhang, Hai-Yan Tu, Lin Wu, Jifeng Feng, Yiping Zhang, Alexander Luft, Jianying Zhou, Zhiyong Ma, You Lü, Chengping Hu, Yuankai Shi, Christine Baudelet, Junliang Cai, Jianhua Chang - Journal of Thoracic Oncology 2019 cited by 358

  15. D-1553 (Garsorasib), a Potent and Selective Inhibitor of KRASG12C in Patients With NSCLC: Phase 1 Study Results

    Authors: Ziming Li, Zhengbo Song, Yanqiu Zhao, Pingli Wang, Liyan Jiang, Yi Gong, Jianying Zhou, Hong Jian, Xiaorong Dong, Zhuang Wu, Shundong Cang, Nong Yang, Jian Fang, Jianhua Shi, Jun‐Guo Lu, Rui Ma, Ping Wu, Yingqian Zhang, Mengmeng Song, Chunwei Xu, Zhe Shi, Ling Zhang, Yaolin Wang, Xicheng Wang, Yiping Zhang, Shun Lü - Journal of Thoracic Oncology 2023 cited by 81

  16. Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

    Authors: Caicun Zhou, Xingya Li, Qiming Wang, Guanghui Gao, Yiping Zhang, Jianhua Chen, Yongqian Shu, Yanping Hu, Yun Fan, Jian Fang, Gongyan Chen, Jun Zhao, Jianxing He, Fengying Wu, Jianjun Zou, Xiaoyu Zhu, Xiang Lin - Journal of Clinical Oncology 2020 cited by 206

  17. Understanding the mechanism of starch digestion mitigation by rice protein and its enzymatic hydrolysates

    Authors: Chengdeng Chi, Xiaoxi Li, Yiping Zhang, Ling Chen, Lin Li - Food Hydrocolloids 2018 cited by 202

  18. Digestibility and supramolecular structural changes of maize starch by non-covalent interactions with gallic acid

    Authors: Chengdeng Chi, Xiaoxi Li, Yiping Zhang, Ling Chen, Lin Li, Zhijiang Wang - Food & Function 2017 cited by 182

  19. Dry heating and annealing treatment synergistically modulate starch structure and digestibility

    Authors: Chengdeng Chi, Xiaoxi Li, Ping Lu, Song Miao, Yiping Zhang, Ling Chen - International Journal of Biological Macromolecules 2019 cited by 141

  20. Reward-Robust RLHF in LLMs

    Authors: Yan, Yuzi, X. C. Lou, Jialian Li, Yiping Zhang, Jian Jun Xie, Chao Yu, Yu Wang, Yan Dong, Yuan Shen - arXiv (Cornell University), CoRR 2024 cited by 27

  21. New insights into how starch structure synergistically affects the starch digestibility, texture, and flavor quality of rice noodles

    Authors: Shaodan Shen, Chengdeng Chi, Yiping Zhang, Lin Li, Ling Chen, Xiaoxi Li - International Journal of Biological Macromolecules 2021 cited by 78

  22. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study

    Authors: Caicun Zhou, Sang-We Kim, Thanyanan Reungwetwattana, Jianying Zhou, Yiping Zhang, Jianxing He, Jin-Ji Yang, Ying Cheng, Se‐Hoon Lee, Lilian Bu, Tingting Xu, Li Yang, Chao Wang, Ting Liu, Peter N. Morcos, You Lu, Li Zhang - The Lancet Respiratory Medicine 2019 cited by 272

  23. Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway

    Authors: Xinran Liu, Yiping Zhang, Yijie Wang, Mei-wen Yang, Fen‐Fang Hong, Shu‐Long Yang - Biomolecules 2021 cited by 91

  24. Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors

    Authors: Anish Thomas, Christophe E. Redon, Linda Sciuto, Emerson Padiernos, Jiuping Ji, Min-Jung Lee, Akira Yuno, Sunmin Lee, Yiping Zhang, Lan Tran, William H. Yutzy, Arun Rajan, Udayan Guha, Haobin Chen, Raffit Hassan, Christine Alewine, Éva Szabó, Susan E. Bates, Robert J. Kinders, Seth M. Steinberg, James H. Doroshow, Mirit I. Aladjem, Jane B. Trepel, Yves Pommier - Journal of Clinical Oncology 2017 cited by 174